US Dollar Risks Collapse on Dow Surge…If this is a True Risk Rally

US Dollar Risks Collapse on Dow Surge…If this is a True Risk Rally

Financial Investment Centre -

Dollar at Risk of Fresh Plunge as Dow Moves to Test Multi-Year Highs

Dollar at Risk of Fresh Plunge as Dow Moves to Test Multi-Year Highs

Financial Investment Centre -

Macy’s January same-store sales up 2.4 percent

Macy's Inc. said Thursday that revenue at stores open at least a year rose 2.4 percent in January on higher online sales, but fell short of Wall Street expectations.The Cincinnati-based department store ...

Financial Investment Centre -

Ross Stores January same-store sales up 5 percent

Ross Stores Inc. said Thursday that revenue at stores open at least a year rose 5 percent in January on rising sales of children's apparel, beating Wall Street expectations.The Pleasanton, Calif., discount ...

Financial Investment Centre -

Bank stocks fall amid overall market decline

Goldman Sachs analysts have upgraded Citigroup Inc. and Morgan Stanley, seeing potential upside for the banks' stocks.The Goldman analysts also downgraded Bank of America Corp., noting that it faces a ...

Financial Investment Centre -

Emerging Markets Post Bigger Gains Than US So Far

While the January rally in U.S. stocks may have looked good, investors would have found even more to like in foreign markets-especially in emerging economies.

Financial Investment Centre -

Summary Box: Dow slips; first losing week in 2012

STOCK SLUMP: Stocks mostly fell after the government said the U.S. economy grew more slowly than expected in the last three months of 2011

Financial Investment Centre -

Ultimate Market Recap: Oil Companies Leaking Value, Alcoa Climbs Despite Dow

The entire day on Wall Street in one Cheat Sheet ...

Financial Investment Centre -

STOCKS SURGE AND THE FED SEES LOW INTEREST RATES FOR YEARS: Here’s What You Need To Know

And did you hear about Apple earnings?

Financial Investment Centre -

Sector Wrap: Life science stocks jump on Roche bid

Shares of life science companies rose Wednesday after Swiss drugmaker Roche made a hostile offer to buy Illumina Inc. for $5.7 billion.Illumina makes systems that analyze an individual's DNA, and Roche ...

Financial Investment Centre -